American journal of respiratory and critical care medicine
-
Am. J. Respir. Crit. Care Med. · Aug 2014
Shisa3 Associated with Prolonged Survival through Promoting β-catenin Degradation in Lung Cancer.
Despite advances in treatment and prognosis of non-small cell lung cancer (NSCLC), patient outcomes are still unsatisfactory. ⋯ Our results reveal that Shisa3 acts as a tumor suppressor by acceleration of β-catenin degradation and provide new insight for cancer prognosis and therapy.
-
Am. J. Respir. Crit. Care Med. · Aug 2014
Editorial CommentICU-acquired Weakness, Morbidity, and Death.